|
Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction
|
13 October 2013 |
|
Vitamin D and intervention trials in prostate cancer: from theory to therapy
|
10 October 2013 |
|
Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells
|
09 October 2013 |
|
Fibroblast growth factors
|
08 October 2013 |
|
Role of insulin-like growth factor I signaling in neurodegenerative diseases
|
08 October 2013 |
|
Vitamin D analogs in cancer prevention and therapy: an ancient friend revisited
|
07 October 2013 |
|
Treatment of metastatic breast cancer with somatostatin analogues--a meta-analysis
|
06 October 2013 |
|
The effects of oestrogens on linear bone growth
|
03 October 2013 |
|
Estrogen regulation of growth hormone action
|
03 October 2013 |
|
Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis
|
02 October 2013 |